We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Plastic Bags May Replace Petri Dishes

By LabMedica International staff writers
Posted on 29 Nov 2011
Sealed plastic bags can be modified at atmospheric pressure so that human cells can adhere to and reproduce on their walls. More...


Physicians are increasingly using live cells in their treatments as in blood transfusions and bone marrow transplants, as well as in stem cell therapies and following severe burns.

Scientists at the Fraunhofer Institute for Surface Engineering and Thin Films (Braunschweig, Germany) collaborating with other institutions cultivated the cells in sealed, sterile plastic bags, where the inner surface of the bags has to be modified so that they provide cells with good conditions for survival. The new bags facilitate the sterile handling of cell cultures.

When using the new technology with its sealed bag system, the cells migrate directly into the bag via an injection needle or connected tube systems without coming into contact with their surroundings. The sterile interior of the bags contains nutrient medium and germ-free air or a suitable gas, which been added beforehand. Even during the cultivation period, the containers do not have to be opened, and at the end, the cells can be removed again by injection needle.

If the bags are provided with a three-dimensional structure, cells could attach themselves to it and create artificial skin, nerves, cartilage, or bone, which could be used prosthetically in the patient. In collaboration with the University of Tübingen (Germany) local scientists plan to isolate certain stem cells from tissue samples and investigate on which of the new plastic surfaces they could develop into bone or cartilage.

Kristina Lachmann, PhD, a scientific assistant at the Fraunhofer Institute, explained, "We fill the bags with a specific gas mixture, and apply an electrical voltage. Inside them, for a brief period, plasma is created, i.e., a luminescent, ionized gas, which chemically alters the plastic surface." During this process, the bag remains sterile as plasmas also have a disinfecting action. The advantage of the process is that it operates at atmospheric pressure and is therefore cost-effective, fast, and flexible.

Related Links:
Fraunhofer Institute for Surface Engineering and Thin Films
University of Tübingen


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
Platelet Function Analyzer
PL-12
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.